NOS2 and COVID-19: In contrast, most research on NOS polymorphisms in COVID-19 has focused on the endothelial isoform (eNOS/NOS3), with some studies suggesting that variants in NOS3 may influence disease course in specific populations—particularly younger individuals without comorbidities—via effects on vascular and OS pathways.